logo

GILD

Gilead Sciences·NASDAQ
--
--(--)
--
--(--)

GILD fundamentals

Gilead Sciences (GILD) expects to report earnings on Feb 10, 2026, with estimated revenue of 7.69B (YoY +1.60%), and EPS at 1.8099 (YoY -4.74%).
Revenue estimate / YoY
7.69B
+1.60%
EPS estimate / YoY
1.8099
-4.74%
Report date
Feb 10, 2026
Earnings Call
4:30 PM on Feb 10, 2026
Meeting link.
EPS
Revenue

Revenue & Expenses

GILD has released its 2025 Q3 earnings report, with revenue of 7.77B, reflecting a YoY change of 2.97%, and net profit of 3.05B, showing a YoY change of 143.58%. The Sankey diagram below clearly presents GILD's revenue sources and cost distribution.

Key Indicators

Gilead Sciences (GILD) key financial stats and ratios, covering profitability, financial health, and leverage.
Gilead Sciences (GILD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gilead Sciences (GILD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gilead Sciences (GILD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gilead Sciences (GILD) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gilead Sciences (GILD) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield